LAP3 and cancer: Meanwhile, He and coworkers reported a theragnostic prodrug CPT-Leu that utilizes camptothecin as the fluorescent indicator and drug, which was capable of conducting the chemotherapy toward the LAP overexpression in cancer cells (Figure 18) [73].